Clinical Trials Browser

Terminated × OTHER × Neoplasm, Residual × Clear all

NCT01751425 2025-06-03

Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors

Phase 1 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT03537599 2025-05-21

Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant

Phase 1/2 Terminated

4 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT01743807 2025-01-27

Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Phase 1 Terminated

4 enrolled 6 charts

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05601830 2024-11-06

Natural Killer(NK) Cell Therapy for AML Minimal Residual Disease

Phase 1 Terminated

Neoplasm, Residual

NCT04920188 2024-07-05

Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT04785547 2024-01-16

ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Phase EARLY_PHASE1 Terminated

2 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03549351 2022-09-13

PERDAM

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT04044560 2022-02-21

OZM-097

Phase 2 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01158885 2021-10-26

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Phase 2 Terminated

2 enrolled 7 charts

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02767934 2020-08-20

Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia

Phase 2 Terminated

12 enrolled 12 charts

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT01392170 2015-05-04

Pegasys in Patients With Chronic Myeloid Leukemia (CML)

Phase 2 Terminated

2 enrolled 3 charts

MyeloidOther hematologic neoplasm

Leukemia, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual